Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.46
0.00 (0.00%)
Sep 18, 2024, 1:31 PM EDT - Market open
Abeona Therapeutics Revenue
In the year 2023, Abeona Therapeutics had annual revenue of $3.50M with 147.52% growth.
Revenue (ttm)
$3.50M
Revenue Growth
+147.52%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
84
Market Cap
236.50M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AirSculpt Technologies | 193.03M |
LifeMD | 178.28M |
Nektar Therapeutics | 93.16M |
Utah Medical Products | 46.58M |
Nanobiotix | 40.02M |
Alpha Teknova | 34.94M |
Cellectis | 19.64M |
ABEO News
- 15 days ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission - GlobeNewsWire
- 2 months ago - Abeona: BLA Resubmission Of Pz-Cel Gets Ball Rolling Towards Other Milestones - Seeking Alpha
- 2 months ago - Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications - GlobeNewsWire
- 2 months ago - Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum - GlobeNewsWire